Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3685201012 | Ethinylestradiol and norelgestromin in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3685202017 | Product containing ethinylestradiol and norelgestromin in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3685203010 | Product containing ethinylestradiol and norelgestromin in transdermal dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3685204016 | Ethinyl estradiol and norelgestromin in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3709902015 | Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3709903013 | Ethinyl estradiol- and norelgestromin-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3709904019 | Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Some | ||
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Has active ingredient | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Is a | Ethinylestradiol- and norelgestromin-containing product | true | Inferred relationship | Some | ||
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Has active ingredient | Norelgestromin | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some | ||
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form | true | Inferred relationship | Some | ||
| Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Is a | Estradiol-containing product in transdermal dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ethinylestradiol and norelgestromin only product in transdermal dose form | Is a | True | Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Inferred relationship | Some | |
| Ethinyl oestradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch | Is a | False | Ethinylestradiol- and norelgestromin-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR